Professional Documents
Culture Documents
Vjezbe - Infektivna Anemija Kokosi
Vjezbe - Infektivna Anemija Kokosi
SARAJEVO, 2010.
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 2
UVOD
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 3
EPIDEMIOLOGIJA
7 ŠIROKA DISTRIBUCIJA
7 PRIRODNI DOMAĆIN KOKOŠ (ĆURKE I PREPELICE)
7 KLINIČKI MANIFESTNO OBOLJENJE KOD?
7 KONTAGIOZNOST?
7 TRANSMISIJA VIRUSA?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 4
7 DEPRESIJA
7 ANOREKSIJA I GUBITAK TJELESNE TEŽINE
7 ANEMIJA (HCT ≤ 27) I USPORENA KOAGULACIJA KRVI
7 POVEĆAN MORTALITET (OBIČNO U DOBI OD 13 – 16
DANA)
7 SEROKONVERZIJA I KLINIČKE MANIFESTACIJE?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 5
PATOGENEZA
7 PERIOD INKUBACIJE?
7 DISTRIBUCIJA
7 VRSTA DOMAĆINA/DOB
7 CILJNE STANICE
7 IMUNOSUPRESIJA!!!
7 EKONOMSKI IMPAKT
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 6
PATOMORFOLOŠKE LEZIJE
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 7
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 8
HEMORAGIJE KRILA
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 9
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 10
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 11
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 12
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 13
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 14
EKONOMSKI ZNAČAJ*
* McNulty, M.S., McIlroy, S.G., Bruce, D.W. & Todd, D. (1991). Economic effects
of subclinical chicken anemia agent infection in broiler chickens. Avian Diseases,
35, 263– 268.
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 15
DIJAGNOZA
7 KLINIČKA SLIKA?
7 PATOMORFOLOŠKE LEZIJE
7 LABORATORIJSKI TESTOVI
7 VIRALNI GENOM (PCR)
7 IZOLACIJA (SPF JAJA)
7 DETEKCIJA ANTIGENA (IF TEST)
7 DETEKCIJA ANTITIJELA (VN TEST I ELISA)
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________
Slide 16
THANK YOU!
teufik.goletic@vfs.unsa.ba
dr. Teufik Goletić
teufikg@gmail.com
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
____________________________________________________________________